Janus Henderson Global Life Sciences Fund
Janus Henderson Global Life Sciences Fund (JFNIX) Stock Overview
Explore Janus Henderson Global Life Sciences Fund’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4.4B
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
N/A
JFNIX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Janus Henderson Global Life Sciences Fund (JFNIX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $78.89.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 4.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.
Janus Investment Fund, MA
2009